Mechanism-based PK/PD modeling of selective serotonin reuptake inhibitors

Geldof, M.

The main objective of the investigations was to explore the PK/PD correlations of fluvoxamine, as a prototype for the Selective Serotonin Reuptake Inhibitors (SSRIs). In the various investigations, a spectrum of different biomarkers was used, each reflecting a specific process on the causal path between drug administration and response. The effects of fluvoxamine have been explored in six investigation steps; from the relatively simple description of the pharmacokinetics of fluvoxamine in plasma and brain to the more complex relationships with the effects on SERT occupancy, 5-HT and 5-HIAA levels and REM sleep. In the PCA study, a categorical PK/PD model was proposed for the effects of fluvoxamine on PCA induced behavioral effects as a kind of intermediary biomarker. There appeared to be important aspects in the PK/PD relationships of fluvoxamine, which was already indicated in the well-known delayed therapeutic effect of SSRIs. The cascading PK/PD model enables the prediction of...Show moreThe main objective of the investigations was to explore the PK/PD correlations of fluvoxamine, as a prototype for the Selective Serotonin Reuptake Inhibitors (SSRIs). In the various investigations, a spectrum of different biomarkers was used, each reflecting a specific process on the causal path between drug administration and response. The effects of fluvoxamine have been explored in six investigation steps; from the relatively simple description of the pharmacokinetics of fluvoxamine in plasma and brain to the more complex relationships with the effects on SERT occupancy, 5-HT and 5-HIAA levels and REM sleep. In the PCA study, a categorical PK/PD model was proposed for the effects of fluvoxamine on PCA induced behavioral effects as a kind of intermediary biomarker. There appeared to be important aspects in the PK/PD relationships of fluvoxamine, which was already indicated in the well-known delayed therapeutic effect of SSRIs. The cascading PK/PD model enables the prediction of the effects of functional adaptation upon long-term administration. For SSRIs, adaptation may occur at various levels in the biological system. The various studied biomarkers provide a basis to determine at which level of the biological system functional adaptation occurs (i.e. target site distribution, target expression, turnover of neurotransmitters, transduction mechanisms).Show less

Leiden University Scholarly Publications

View statistics

Documents

In Collections

Mechanism-based PK/PD modeling of selective serotonin reuptake inhibitors

Funding